Clinical study on anti-fungal drug activity against clinically isolated strains of oral Candida species

The present study was undertaken to evaluate the anti-fungal activity of amphotericin B (AMPH-B), flucytosine (5-FC), fluconazole (FLCZ), miconazole (MCZ), itraconazole (ITCZ), and micafungin (MCFG) against clinically isolated Candida strains from oral candidiasis (OC) patients and to collect inform...

Full description

Saved in:
Bibliographic Details
Published inOral Science International Vol. 10; no. 2; pp. 87 - 94
Main Authors Kamikawa, Yoshiaki, Nagayama, Tomohiro, Fujisaki, Junichi, Hirabayashi, Daisuke, Kawasaki, Kiyotsugu, Hamada, Tomofumi, Mori, Youichiro, Kamikawa, Yasuko, Mukai, Hiroshi, Sato, Tomoaki, Sugihara, Kazumasa
Format Journal Article
LanguageEnglish
Published Elsevier Ltd 01.05.2013
Wiley
Subjects
Online AccessGet full text
ISSN1348-8643
1881-4204
DOI10.1016/S1348-8643(13)00006-2

Cover

Abstract The present study was undertaken to evaluate the anti-fungal activity of amphotericin B (AMPH-B), flucytosine (5-FC), fluconazole (FLCZ), miconazole (MCZ), itraconazole (ITCZ), and micafungin (MCFG) against clinically isolated Candida strains from oral candidiasis (OC) patients and to collect information useful for the treatment of OC. The study includes 116 strains of Candida isolated from patients. The Candida species were identified by polymerase chain reaction. The minimum inhibitory concentration (MIC) of each drug against each Candida species was determined. Of the 106 participants (30 males and 76 females), 57 had OC, including 42 cases of pseudomembranous OC, 11 cases of erythematous OC, 2 cases of hypertrophic OC, and 2 cases of mixed pseudomembranous/erythematous OC. The Candida species isolated were Candida albicans (93 strains), C. glabrata (19 strains), and C. tropicalis (4 strains). AMPH-B and 5-FC had low MIC values against all species of Candida and a low incidence of resistance development. In some species of Candida, FLCZ and ITCZ showed high MICs, but MCZ had a low MIC value. AMPH-B, MCZ, and ITCZ prescribed to OC patients were effective against OC with respect to alleviation of OC symptoms. MIC values of anti-fungal drugs against Candida strains isolated from OC patients were obtained and the 3 anti-fungal drugs given to OC patients were found to be effective against OC in spite of differences in their MIC values and in the number of resistant strains (or strains with a high MIC value).
AbstractList The present study was undertaken to evaluate the anti-fungal activity of amphotericin B (AMPH-B), flucytosine (5-FC), fluconazole (FLCZ), miconazole (MCZ), itraconazole (ITCZ), and micafungin (MCFG) against clinically isolated Candida strains from oral candidiasis (OC) patients and to collect information useful for the treatment of OC. The study includes 116 strains of Candida isolated from patients. The Candida species were identified by polymerase chain reaction. The minimum inhibitory concentration (MIC) of each drug against each Candida species was determined. Of the 106 participants (30 males and 76 females), 57 had OC, including 42 cases of pseudomembranous OC, 11 cases of erythematous OC, 2 cases of hypertrophic OC, and 2 cases of mixed pseudomembranous/erythematous OC. The Candida species isolated were Candida albicans (93 strains), C. glabrata (19 strains), and C. tropicalis (4 strains). AMPH-B and 5-FC had low MIC values against all species of Candida and a low incidence of resistance development. In some species of Candida, FLCZ and ITCZ showed high MICs, but MCZ had a low MIC value. AMPH-B, MCZ, and ITCZ prescribed to OC patients were effective against OC with respect to alleviation of OC symptoms. MIC values of anti-fungal drugs against Candida strains isolated from OC patients were obtained and the 3 anti-fungal drugs given to OC patients were found to be effective against OC in spite of differences in their MIC values and in the number of resistant strains (or strains with a high MIC value).
Objectives: The present study was undertaken to evaluate the anti‐fungal activity of amphotericin B (AMPH‐B), flucytosine (5‐FC), fluconazole (FLCZ), miconazole (MCZ), itraconazole (ITCZ), and micafungin (MCFG) against clinically isolated Candida strains from oral candidiasis (OC) patients and to collect information useful for the treatment of OC. Subjects and methods: The study includes 116 strains of Candida isolated from patients. The Candida species were identified by polymerase chain reaction. The minimum inhibitory concentration (MIC) of each drug against each Candida species was determined. Results: Of the 106 participants (30 males and 76 females), 57 had OC, including 42 cases of pseudomembranous OC, 11 cases of erythematous OC, 2 cases of hypertrophic OC, and 2 cases of mixed pseudomembranous/erythematous OC. The Candida species isolated were Candida albicans (93 strains), C. glabrata (19 strains), and C. tropicalis (4 strains). AMPH‐B and 5‐FC had low MIC values against all species of Candida and a low incidence of resistance development. In some species of Candida, FLCZ and ITCZ showed high MICs, but MCZ had a low MIC value. AMPH‐B, MCZ, and ITCZ prescribed to OC patients were effective against OC with respect to alleviation of OC symptoms. Conclusion: MIC values of anti‐fungal drugs against Candida strains isolated from OC patients were obtained and the 3 anti‐fungal drugs given to OC patients were found to be effective against OC in spite of differences in their MIC values and in the number of resistant strains (or strains with a high MIC value).
Objectives: The present study was undertaken to evaluate the anti‐fungal activity of amphotericin B (AMPH‐B), flucytosine (5‐FC), fluconazole (FLCZ), miconazole (MCZ), itraconazole (ITCZ), and micafungin (MCFG) against clinically isolated Candida strains from oral candidiasis (OC) patients and to collect information useful for the treatment of OC. Subjects and methods: The study includes 116 strains of Candida isolated from patients. The Candida species were identified by polymerase chain reaction. The minimum inhibitory concentration (MIC) of each drug against each Candida species was determined. Results: Of the 106 participants (30 males and 76 females), 57 had OC, including 42 cases of pseudomembranous OC, 11 cases of erythematous OC, 2 cases of hypertrophic OC, and 2 cases of mixed pseudomembranous/erythematous OC. The Candida species isolated were Candida albicans (93 strains), C . glabrata (19 strains), and C. tropicalis (4 strains). AMPH‐B and 5‐FC had low MIC values against all species of Candida and a low incidence of resistance development. In some species of Candida , FLCZ and ITCZ showed high MICs, but MCZ had a low MIC value. AMPH‐B, MCZ, and ITCZ prescribed to OC patients were effective against OC with respect to alleviation of OC symptoms. Conclusion: MIC values of anti‐fungal drugs against Candida strains isolated from OC patients were obtained and the 3 anti‐fungal drugs given to OC patients were found to be effective against OC in spite of differences in their MIC values and in the number of resistant strains (or strains with a high MIC value).
Author Hirabayashi, Daisuke
Kawasaki, Kiyotsugu
Sato, Tomoaki
Nagayama, Tomohiro
Sugihara, Kazumasa
Mori, Youichiro
Kamikawa, Yasuko
Mukai, Hiroshi
Fujisaki, Junichi
Hamada, Tomofumi
Kamikawa, Yoshiaki
Author_xml – sequence: 1
  givenname: Yoshiaki
  surname: Kamikawa
  fullname: Kamikawa, Yoshiaki
  email: zenkamikawa@mac.com, kamikawa@dent.kagoshima-u.ac.jp
  organization: Department of Oral Surgery, Kagoshima University Hospital, 8-35-1 Sakuragaoka, Kagoshima 890-8544, Japan
– sequence: 2
  givenname: Tomohiro
  surname: Nagayama
  fullname: Nagayama, Tomohiro
  organization: Department of Applied Pharmacology, Field of Functional Biology and Pharmacology, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan
– sequence: 3
  givenname: Junichi
  surname: Fujisaki
  fullname: Fujisaki, Junichi
  organization: Department of Maxillofacial Diagnostic and Surgical Science, Field of Oral and Maxillofacial Rehabilitation, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan
– sequence: 4
  givenname: Daisuke
  surname: Hirabayashi
  fullname: Hirabayashi, Daisuke
  organization: Department of Maxillofacial Diagnostic and Surgical Science, Field of Oral and Maxillofacial Rehabilitation, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan
– sequence: 5
  givenname: Kiyotsugu
  surname: Kawasaki
  fullname: Kawasaki, Kiyotsugu
  organization: Department of Maxillofacial Diagnostic and Surgical Science, Field of Oral and Maxillofacial Rehabilitation, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan
– sequence: 6
  givenname: Tomofumi
  surname: Hamada
  fullname: Hamada, Tomofumi
  organization: Department of Maxillofacial Diagnostic and Surgical Science, Field of Oral and Maxillofacial Rehabilitation, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan
– sequence: 7
  givenname: Youichiro
  surname: Mori
  fullname: Mori, Youichiro
  organization: Department of Maxillofacial Diagnostic and Surgical Science, Field of Oral and Maxillofacial Rehabilitation, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan
– sequence: 8
  givenname: Yasuko
  surname: Kamikawa
  fullname: Kamikawa, Yasuko
  organization: Department of Maxillofacial Diagnostic and Surgical Science, Field of Oral and Maxillofacial Rehabilitation, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan
– sequence: 9
  givenname: Hiroshi
  surname: Mukai
  fullname: Mukai, Hiroshi
  organization: Department of Oral Surgery, Kagoshima University Hospital, 8-35-1 Sakuragaoka, Kagoshima 890-8544, Japan
– sequence: 10
  givenname: Tomoaki
  surname: Sato
  fullname: Sato, Tomoaki
  organization: Department of Applied Pharmacology, Field of Functional Biology and Pharmacology, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan
– sequence: 11
  givenname: Kazumasa
  surname: Sugihara
  fullname: Sugihara, Kazumasa
  organization: Department of Oral Surgery, Kagoshima University Hospital, 8-35-1 Sakuragaoka, Kagoshima 890-8544, Japan
BackLink https://cir.nii.ac.jp/crid/1872835442410445184$$DView record in CiNii
BookMark eNqNkE1rHSEUhqUk0CTtTyi46CJdTOpRx3EIpZRLviCQRdK1eNW5nDJ1gnpT5t_HuTfZZJO60IO-j0efY3IQpxgI-QLsDBio7_cgpG60kuIUxDdWh2r4B3IEWkMjOZMHtX6NfCTHOf9hrFW9UEdksxoxorMjzWXrZzpFamPBZtjGTd30abuh1hV8wjJTu7EYc6HuhRlninkabQm-4mk5pNNAp1TJlY0evaX5MTgM-RM5HOyYw-eX9YT8vrx4WF03t3dXN6tft42TmvPGgRWyg06t170UAQT3odO25V1grVR-3WrHlLaq56rrOOvBStt7zjsY1o4zcULa_b0uTTmnMJjHhH9tmg0ws9gyO1tmUWFAmJ0twyt3_oZzWGzBKS7_Gt-lf-zpfziG-f9amrv7G76rF_7rno-ItfEyg-64Fq2UXAKTsgUta-znPhaqwScMyeTqNrrgMQVXjJ_wnYc-Az3Codg
CitedBy_id crossref_primary_10_1007_s10096_014_2240_6
crossref_primary_10_1186_1472_6831_14_14
Cites_doi 10.1128/JCM.02434-08
10.1111/j.1399-302X.2005.00236.x
10.1093/jac/dkh053
10.1128/JCM.36.7.1886-1889.1998
10.1186/1471-2180-8-135
10.1086/423377
10.1002/yea.892
10.1086/596757
10.1086/323401
10.1254/fpj.130.69
10.1016/S0732-8893(02)00440-6
10.1016/S0002-9343(02)01191-9
10.1086/423378
ContentType Journal Article
Copyright 2013 Japanese Stomatological Society
Copyright_xml – notice: 2013 Japanese Stomatological Society
DBID 6I.
AAFTH
RYH
AAYXX
CITATION
DOI 10.1016/S1348-8643(13)00006-2
DatabaseName ScienceDirect Open Access Titles
Elsevier:ScienceDirect:Open Access
CiNii Complete
CrossRef
DatabaseTitle CrossRef
DatabaseTitleList

CrossRef
DeliveryMethod fulltext_linktorsrc
Discipline Dentistry
EISSN 1881-4204
EndPage 94
ExternalDocumentID 10_1016_S1348_8643_13_00006_2
OSI2000062
S1348864313000062
Genre article
GroupedDBID --K
--M
.55
.~1
0R~
1OC
1~.
2WC
33P
34H
4.4
457
4G.
6I.
7-5
8P~
AACTN
AAEDT
AAEDW
AAFTH
AAHHS
AAIKJ
AALRI
AANLZ
AAOAW
AAXUO
ABBQC
ABCUV
ABGSF
ABJNI
ABMAC
ABMZM
ABQWH
ABVKL
ABXDB
ABYKQ
ACCFJ
ACCZN
ACGFS
ACGOF
ACPOU
ACXQS
ADBBV
ADBTR
ADEZE
ADKYN
ADMUD
ADUVX
ADXAS
ADZMN
AEEZP
AEIGN
AEKER
AEQDE
AEUYR
AEXQZ
AFFPM
AGHFR
AGUBO
AGYEJ
AHBTC
AITUG
AIURR
AIWBW
AJBDE
AJOXV
AJRQY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMFUW
AMRAJ
AMYDB
ANZVX
BFHJK
BLXMC
C45
DCZOG
DOVZS
EBS
EFLBG
EJD
FDB
FEDTE
FIRID
FNPLU
GBLVA
HVGLF
HZ~
JSF
JSH
KQ8
LATKE
LCYCR
LEEKS
LYRES
M41
MO0
NCXOZ
O-L
O9-
OAUVE
OK1
OVD
P-8
P-9
P2W
PC.
Q38
RJT
ROL
RZJ
SDF
SES
SSZ
SUPJJ
T5K
TEORI
TKC
TR2
WXSBR
X7M
ZZTAW
AAHQN
AAIPD
AAMNL
AAYCA
AAYWO
ACVFH
ADCNI
ADVLN
AEUPX
AEYWJ
AFPUW
AFWVQ
AGYGG
AIGII
AITYG
AKBMS
AKRWK
AKYEP
ALVPJ
HGLYW
RYH
0SF
ABWVN
ACRPL
ADNMO
AAMMB
AAYXX
AEFGJ
AGHNM
AGXDD
AIDQK
AIDYY
CITATION
LH4
~HD
ID FETCH-LOGICAL-c4822-c1a347176bb943e132de78a527e0546db58c068a6926772091a4a9d2271fbc203
IEDL.DBID .~1
ISSN 1348-8643
IngestDate Wed Oct 01 03:28:14 EDT 2025
Thu Apr 24 22:58:57 EDT 2025
Wed Jan 22 16:21:33 EST 2025
Thu Jun 26 21:08:56 EDT 2025
Fri Feb 23 02:29:36 EST 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords Minimal inhibitory concentration
Oral Candida species
Anti-fungal drug activity
Clinically isolated strains
Language English
License http://www.elsevier.com/open-access/userlicense/1.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c4822-c1a347176bb943e132de78a527e0546db58c068a6926772091a4a9d2271fbc203
ORCID 0000-0001-9147-396X
OpenAccessLink https://www.sciencedirect.com/science/article/pii/S1348864313000062
PageCount 8
ParticipantIDs crossref_primary_10_1016_S1348_8643_13_00006_2
crossref_citationtrail_10_1016_S1348_8643_13_00006_2
wiley_primary_10_1016_S1348_8643_13_00006_2_OSI2000062
nii_cinii_1872835442410445184
elsevier_sciencedirect_doi_10_1016_S1348_8643_13_00006_2
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate May 2013
PublicationDateYYYYMMDD 2013-05-01
PublicationDate_xml – month: 05
  year: 2013
  text: May 2013
PublicationDecade 2010
PublicationTitle Oral Science International
PublicationYear 2013
Publisher Elsevier Ltd
Wiley
Publisher_xml – name: Elsevier Ltd
– name: Wiley
References Pfaller, Jones, Doern (bib0005) 1998; 36
(bib0110) 2011
Yamaguchi, Enomoto, Kaku (bib0100) 2006; 54
Yamaguchi, Uchida, Nishiyama (bib0045) 2006; 16
Kanbe, Horii, Arishima (bib0055) 2002; 19
Villanueva, Arathoon, Gotuzzo (bib0015) 2001; 33
Clinical and Laboratory Standards Institute (bib0065) 2008
Messer, Moet, Kirby (bib0010) 2009; 47
Villanueva, Gotuzzo, Arathoon (bib0020) 2002; 113
Yamaguchi, Uchida, Okuzumi (bib0040) 2004; 14
Hamza, Matee, Moshi (bib0090) 2008; 8
Yamaguchi, Nishiyama, Uchida (bib0050) 2009; 19
Pappas, Kauffman, Andes (bib0060) 2009; 48
de Wet, Llanos-Cuentas, Suleiman (bib0025) 2004; 39
Yamaguchi (bib0070) 2009; 55
Takakura, Fujihara, Saito (bib0035) 2004; 53
Sudo, Makimura, Kawata (bib0075) 1997; 45
Blignaut, Messer, Hollis (bib0080) 2002; 44
Kuriyama, Williams, Bagg (bib0085) 2005; 20
Krause, Simjee, van Rensburg (bib0030) 2004; 39
Otani, Unoue, Shiota (bib0105) 2007; 130
Yamaguchi (bib0095) 2010; 56
Yamaguchi H (e_1_2_7_1_10_2) 2006; 16
e_1_2_7_1_22_2
e_1_2_7_1_12_2
e_1_2_7_1_8_2
Yamaguchi H (e_1_2_7_1_21_2) 2006; 54
Yamaguchi H (e_1_2_7_1_11_2) 2009; 19
(e_1_2_7_1_23_2) 2011
Sudo T (e_1_2_7_1_16_2) 1997; 45
Yamaguchi H. (e_1_2_7_1_15_2) 2009; 55
e_1_2_7_1_4_2
Clinical and Laboratory Standards Institute (e_1_2_7_1_14_2) 2008
e_1_2_7_1_17_2
e_1_2_7_1_5_2
e_1_2_7_1_18_2
e_1_2_7_1_6_2
e_1_2_7_1_19_2
e_1_2_7_1_7_2
e_1_2_7_1_13_2
e_1_2_7_1_2_2
Yamaguchi H. (e_1_2_7_1_20_2) 2010; 56
e_1_2_7_1_3_2
Yamaguchi H (e_1_2_7_1_9_2) 2004; 14
References_xml – start-page: 16
  year: 2011
  ident: bib0110
  article-title: Interview Form FLORID Oral gel 2%
– volume: 20
  start-page: 349
  year: 2005
  end-page: 353
  ident: bib0085
  article-title: In vitro susceptibility of oral
  publication-title: Oral Microbiol Immunol
– volume: 47
  start-page: 1942
  year: 2009
  end-page: 1946
  ident: bib0010
  article-title: Activity of contemporary antifungal agents, including the novel echinocandin anidulafungin, tested against
  publication-title: J Clin Microbiol
– volume: 45
  start-page: 115
  year: 1997
  end-page: 122
  ident: bib0075
  article-title: Evaluation of antifungal susceptibility testing by the broth micro dilution method against
  publication-title: Jpn J Chemother
– volume: 113
  start-page: 294
  year: 2002
  end-page: 299
  ident: bib0020
  article-title: A randomized double-blind study of caspofungin versus fluconazole for the treatment of esophageal candidiasis
  publication-title: Am J Med
– volume: 8
  start-page: 135
  year: 2008
  ident: bib0090
  article-title: Species distribution and in vitro antifungal susceptibility of oral yeast isolates from Tanzanian HIV-infected patients with primary and recurrent oropharyngeal candidiasis
  publication-title: BMC Microbiol
– volume: 33
  start-page: 1529
  year: 2001
  end-page: 1535
  ident: bib0015
  article-title: A randomized double-blind study of caspofungin versus amphotericin for the treatment of candidal esophagitis
  publication-title: Clin Infect Dis
– volume: 36
  start-page: 1886
  year: 1998
  end-page: 1889
  ident: bib0005
  article-title: International surveillance of blood stream infections due to
  publication-title: J Clin Microbiol
– volume: 39
  start-page: 842
  year: 2004
  end-page: 849
  ident: bib0025
  article-title: A randomized, double blind, parallel group, dose-response study of micafungin compared with fluconazole for the treatment of esophageal candidiasis in HIV positive patients
  publication-title: Clin Infect Dis
– volume: 14
  start-page: 183
  year: 2004
  end-page: 193
  ident: bib0040
  article-title: Nationwide survey of antifungal drug susceptibility of clinical fungal isolates in Japan for the Japan Antifungal Surveillance Program (JASP), 2001–2002
  publication-title: J Jpn Soc Clin Microbiol
– volume: 16
  start-page: 13
  year: 2006
  end-page: 22
  ident: bib0045
  article-title: Nationwide survey of antifungal drug susceptibility of clinical fungal isolates in Japan for the Japan Antifungal Surveillance Program (JASP), 2003
  publication-title: J Jpn Soc Clin Microbiol
– volume: 48
  start-page: 503
  year: 2009
  end-page: 535
  ident: bib0060
  article-title: Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America
  publication-title: Clin Infect Dis
– year: 2008
  ident: bib0065
  article-title: Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard-third edition M27-A3
– volume: 56
  start-page: 119
  year: 2010
  end-page: 138
  ident: bib0095
  article-title: Epidemiology of antifungal resistance: current status and future perspective
  publication-title: Modern Media
– volume: 53
  start-page: 283
  year: 2004
  end-page: 289
  ident: bib0035
  article-title: National surveillance of species distribution in blood isolates of
  publication-title: J Antimicrob Chemother
– volume: 54
  start-page: 18
  year: 2006
  end-page: 31
  ident: bib0100
  article-title: An open randomized parallel-comparison study of itraconazole oral solution versus itraconazole capsules in treatment of patients with oropharyngeal candidiasis
  publication-title: Jpn J Chemother
– volume: 19
  start-page: 128
  year: 2009
  end-page: 141
  ident: bib0050
  article-title: Nationwide survey of antifungal drug susceptibility of clinical fungal isolates in Japan for the Japan Antifungal Surveillance Program (JASP), 2005
  publication-title: J Jpn Soc Clin Microbiol
– volume: 19
  start-page: 973
  year: 2002
  end-page: 989
  ident: bib0055
  article-title: PCR-based identification of pathogenic
  publication-title: Yeast
– volume: 130
  start-page: 69
  year: 2007
  end-page: 76
  ident: bib0105
  article-title: Pharmacological, pharmacokinetic, and clinical profile of itraconazole ore solution (ITRIZOLE Oral Solution 1%)
  publication-title: Folia Pharmacol Jpn
– volume: 39
  start-page: 770
  year: 2004
  end-page: 775
  ident: bib0030
  article-title: A randomized, double-blind trial of anidulafungin versus fluconazole for the treatment of esophageal candidiasis
  publication-title: Clin Infect Dis
– volume: 44
  start-page: 169
  year: 2002
  end-page: 174
  ident: bib0080
  article-title: Antifungal susceptibility of South African oral yeast isolates from HIV/AIDS patients and healthy individuals
  publication-title: Diagn Microbiol Infect Dis
– volume: 55
  start-page: 309
  year: 2009
  end-page: 320
  ident: bib0070
  article-title: Anti fungal drug sensitivity test
  publication-title: Modern Media
– ident: e_1_2_7_1_3_2
  doi: 10.1128/JCM.02434-08
– ident: e_1_2_7_1_18_2
  doi: 10.1111/j.1399-302X.2005.00236.x
– ident: e_1_2_7_1_8_2
  doi: 10.1093/jac/dkh053
– volume: 19
  start-page: 128
  year: 2009
  ident: e_1_2_7_1_11_2
  article-title: Nationwide survey of antifungal drug susceptibility of clinical fungal isolates in Japan for the Japan Anti‐fungal Surveillance Program (JASP), 2005
  publication-title: J Jpn Soc Clin Microbiol
– ident: e_1_2_7_1_2_2
  doi: 10.1128/JCM.36.7.1886-1889.1998
– ident: e_1_2_7_1_19_2
  doi: 10.1186/1471-2180-8-135
– ident: e_1_2_7_1_6_2
  doi: 10.1086/423377
– ident: e_1_2_7_1_12_2
  doi: 10.1002/yea.892
– volume: 55
  start-page: 309
  year: 2009
  ident: e_1_2_7_1_15_2
  article-title: Anti fungal drug sensitivity test
  publication-title: Modern Media
– volume-title: Interview Form FLORID Oral gel 2%.
  year: 2011
  ident: e_1_2_7_1_23_2
– volume: 45
  start-page: 115
  year: 1997
  ident: e_1_2_7_1_16_2
  article-title: Evaluation of antifungal susceptibility testing by the broth micro dilution method against Candida species: activities of 5 antifungal agents against Candida species isolated from oral candidiasis or other candidal infectious diseases and correlation of vitro data and clinical outcome of fluconazole therapy
  publication-title: Jpn J Chemother
– volume: 14
  start-page: 183
  year: 2004
  ident: e_1_2_7_1_9_2
  article-title: Nationwide survey of antifungal drug susceptibility of clinical fungal isolates in Japan for the Japan Antifungal Surveillance Program (JASP), 2001–2002
  publication-title: J Jpn Soc Clin Microbiol
– ident: e_1_2_7_1_13_2
  doi: 10.1086/596757
– ident: e_1_2_7_1_4_2
  doi: 10.1086/323401
– ident: e_1_2_7_1_22_2
  doi: 10.1254/fpj.130.69
– ident: e_1_2_7_1_17_2
  doi: 10.1016/S0732-8893(02)00440-6
– start-page: M27
  volume-title: Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard
  year: 2008
  ident: e_1_2_7_1_14_2
– volume: 54
  start-page: 18
  issue: 1
  year: 2006
  ident: e_1_2_7_1_21_2
  article-title: An open randomized parallel‐comparison study of itraconazole oral solution versus itraconazole capsules in treatment of patients with oropharyngeal candidiasis
  publication-title: Jpn J Chemother
– volume: 16
  start-page: 13
  year: 2006
  ident: e_1_2_7_1_10_2
  article-title: Nationwide survey of antifungal drug susceptibility of clinical fungal isolates in Japan for the Japan Anti‐fungal Surveillance Program (JASP), 2003
  publication-title: J Jpn Soc Clin Microbiol
– ident: e_1_2_7_1_5_2
  doi: 10.1016/S0002-9343(02)01191-9
– ident: e_1_2_7_1_7_2
  doi: 10.1086/423378
– volume: 56
  start-page: 119
  year: 2010
  ident: e_1_2_7_1_20_2
  article-title: Epidemiology of antifungal resistance: current status and future perspective
  publication-title: Modern Media
SSID ssj0056936
ssib058494013
ssib050995472
Score 1.8605108
Snippet The present study was undertaken to evaluate the anti-fungal activity of amphotericin B (AMPH-B), flucytosine (5-FC), fluconazole (FLCZ), miconazole (MCZ),...
Objectives: The present study was undertaken to evaluate the anti‐fungal activity of amphotericin B (AMPH‐B), flucytosine (5‐FC), fluconazole (FLCZ),...
Objectives: The present study was undertaken to evaluate the anti‐fungal activity of amphotericin B (AMPH‐B), flucytosine (5‐FC), fluconazole (FLCZ),...
SourceID crossref
wiley
nii
elsevier
SourceType Enrichment Source
Index Database
Publisher
StartPage 87
SubjectTerms Anti-fungal drug activity
Clinically isolated strains
Minimal inhibitory concentration
Oral Candida species
Title Clinical study on anti-fungal drug activity against clinically isolated strains of oral Candida species
URI https://dx.doi.org/10.1016/S1348-8643(13)00006-2
https://cir.nii.ac.jp/crid/1872835442410445184
https://onlinelibrary.wiley.com/doi/abs/10.1016%2FS1348-8643%2813%2900006-2
Volume 10
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVESC
  databaseName: Baden-Württemberg Complete Freedom Collection (Elsevier)
  customDbUrl:
  eissn: 1881-4204
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0056936
  issn: 1348-8643
  databaseCode: GBLVA
  dateStart: 20110101
  isFulltext: true
  titleUrlDefault: https://www.sciencedirect.com
  providerName: Elsevier
– providerCode: PRVESC
  databaseName: Elsevier ScienceDirect
  customDbUrl:
  eissn: 1881-4204
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0056936
  issn: 1348-8643
  databaseCode: .~1
  dateStart: 20040501
  isFulltext: true
  titleUrlDefault: https://www.sciencedirect.com
  providerName: Elsevier
– providerCode: PRVLSH
  databaseName: Elsevier Journals
  customDbUrl:
  mediaType: online
  eissn: 1881-4204
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0056936
  issn: 1348-8643
  databaseCode: AKRWK
  dateStart: 20040501
  isFulltext: true
  providerName: Library Specific Holdings
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV09SzQxEA6-Ntq8-InnFykstIi3yWY32VJORQW18BXsQrJJjoVjT_wobPztzmT3TixeFJstQhKGyZB5ws4zDyEHobZcucwyz-GlIy13TMfIWeA8jxWP0UYkJ1_flBf38uqheFggoxkXBssq-7u_u9PTbd2PDHtvDh-bZnjHcwg-SKj4QwapgMhglwpVDI7f52UeRVklmUCczHD2J4un2yENHvL8KG3CxP_y05-2ab4C2JSBzlfI3x460pPOulWyENo1snSK5T6o2LZOxn2TzwlNTWPptKXgt4ZB7oI8QP3T65gijwHlIqgd2wagIZ1RIydvtIE4BOjp6XMSjnim00iRwE9HyH3xliItE17WG-T-_Ozf6IL1QgqslgAAWM1tDklIlc5VMg_wAPVBaVsIFQCxld4Vus5KbctKlIC2AUJYaSsvhOLR1SLLN8liO23DFqEBG9BpX4c6c1LFXBfWRVX56GLmgrcDImfuM3XfZRxtnph5ORl63aDXDc9N8roRA3I8X_bYtdn4boGenY35Ei8GUsF3S_fgLME6_HKtsOOclIBkMmzWpuWAlOmUf2aIub27FF0Abv_eph2yLJLOBlZS7pLFl6fXsAdo58Xtp3D-AClx8Xg
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV07b9wwDCbyGNIl6CNFL20aDR2aQTlLlm15LK4NLs2jQxIgmyBZ0sHAwRfkMWTpby8p-67IUKTI4kGQBIIkxI8wPxLgS2isqFxmuReY6SgrHNcxCh6EyGMtYrSRyMln5-X0Sv28Lq7XYLLkwlBZ5fD29296eq2HlfGgzfFN244vRI7OhwGVfsgQFXAdNlUhK8rADn-v6jyKsk5zAmk3p-1_aTz9FWnxq8gP0i1c_itArXdt-xTBphB09Bq2B-zIvvXivYG10L2Fre9U70Mj297BbOjyOWepayxbdAwV13IMXhgImL99mDEiMtC8CGZntkVsyJbcyPkja9EREXt6dpcmR9yxRWTE4GcTIr94y4iXian1Dlwd_bicTPkwSYE3ChEAb4TNMQpVpXO1ygNmoD5U2qK2AkK20rtCN1mpbVnLEuE2YgirbO2lrER0jczy97DRLbrwAVigDnTaN6HJnKpirgvrYlX76GLmgrcjUEv1mWZoM04yz82qnoy0bkjrRuQmad3IERyujt30fTaeO6CXtjFPHMZgLHju6B7aEqWjr9AVtZxTCqFMRt3atBpBmaz8f4KYXxfHsvfA3ZfLtA9b08uzU3N6fH7yEV7JNHSDyio_wcb97UPYQ-hz7z4n1_4DZdz0mw
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Clinical+study+on+anti%E2%80%90fungal+drug+activity+against+clinically+isolated+strains+of+oral+Candida+species&rft.jtitle=Oral+science+international&rft.au=Kamikawa%2C+Yoshiaki&rft.au=Nagayama%2C+Tomohiro&rft.au=Fujisaki%2C+Junichi&rft.au=Hirabayashi%2C+Daisuke&rft.date=2013-05-01&rft.issn=1348-8643&rft.eissn=1881-4204&rft.volume=10&rft.issue=2&rft.spage=87&rft.epage=94&rft_id=info:doi/10.1016%2FS1348-8643%2813%2900006-2&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_S1348_8643_13_00006_2
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1348-8643&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1348-8643&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1348-8643&client=summon